ArticleOrthopaedic journal of sports medicine2024
Translation and Validation of the Spanish Version of the Banff Patellofemoral Instability Instrument 2.0.
Article in Orthopaedic journal of sports medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Translation and Validation of the Canadian-French Version of the Banff Patellofemoral Instability Instrument (BPII 2.0-CF).Orthopaedic journal of sports medicine · 2026Article
- Translation, cross-cultural validity and reliability of a Danish version of the Banff Patella Instability Instrument 2.0 (BPII 2.0).Journal of experimental orthopaedics · 2026Article
- Cross-Cultural Adaptation and Validation of the Norwich Patellar Instability (NPI) Score and the Banff Patellofemoral Instability Instrument (BPII) 2.0 in a Polish Pediatric Population.Children (Basel, Switzerland) · 2025Article
- Polish Validation and Language Adaptation of the Banff Patellofemoral Instability Instrument 2.0.Orthopaedic journal of sports medicine · 2025Article
- Translation and Validation of the Spanish Version of the Norwich Patellofemoral Instability (NPI) Score.Orthopaedic journal of sports medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Banff Patellofemoral Instability Instrument (BPII) 2.0 is a patient-reported outcome measure (PROM) tailored specifically for patellofemoral instability. The BPII 2.0 was developed in English and has been validated for adolescents and translated into several languages, but not into Spanish. Purpose/Hypothesis: This investigation involved translating the BPII 2.0 into Spanish and evaluating and validating its psychometric properties. It was hypothesized that there would be a moderate correlation between the Spanish BPII 2.0 and the Spanish version of the Kujala score. Study Design: Cohort study (diagnosis); Level of evidence, 3. Methods: The BPII 2.0 underwent forward and backward translations into Colombian Spanish according to the Consensus-Based Standards for the Selection of Health Measurement Instrument guidelines. Colombian patients aged 9 to 18 years who experienced knee symptoms after a primary or recurrent patellar dislocation were recruited from a hospital-based orthopaedic clinic. Participants completed the Spanish BPII 2.0 and the Kujala score during their initial visit (t Results: A total of 46 participants (31 [67%] female; mean age, 15.1 ± 2.0 years) were included. The mean time since first patellofemoral dislocation was 22 ± 28 months. Of the 4 participants who received operative treatment for patellar instability, the mean time since surgery was 12 months (range, 7-18 months). All patients completed the BPII 2.0 at t Conclusion: The Spanish BPII 2.0 had excellent internal consistency and test-retest reliability, suggesting this PROM is a reliable and valid questionnaire.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.